RevitalVision

What RevitalVision does

RevitalVision (legal entity Talshir Guy Medical Technologies Ltd., headquartered in Modi'in, Israel, and previously operating as NeuroVision) develops and commercializes a web-based perceptual-learning software platform that delivers vision-training programs to patients with amblyopia, presbyopia, post-cataract and post-LASIK residual blur, low myopia, eye diseases (nystagmus, keratoconus, Stargardt disease, macular degeneration), and athletes seeking sports-vision enhancement. The platform uses proprietary Gabor-patch visual stimulation to drive neuroplastic changes in the visual cortex, with programs consisting of roughly 30-minute sessions performed three to four times per week for two to four months on a standard computer. The amblyopia program holds FDA clearance and the company holds a CE mark, supported by publications in Nature, PNAS, and the British Journal of Ophthalmology.

The company operates a hybrid go-to-market combining direct-to-consumer e-commerce (revitalvision.com and store.revitalvision.com with an online eligibility test) with a B2B2C channel in which ophthalmic and optometry clinics prescribe and remotely monitor treatment through a dedicated doctor portal. International distribution is handled through exclusive partners Optik Medikal in Turkey and Vietcare Solutions in Vietnam, with localized websites in Spanish, Hebrew, Turkish, Vietnamese, Arabic, and Romanian. Revenue is generated through per-program fees (sometimes described as multi-month subscriptions) and clinic licensing; pricing is not publicly disclosed and a 14-day money-back guarantee is offered on direct purchases. Over 15,000 patients have been treated to date, and a CPT code (0687T) exists for amblyopia treatment via online digital programs in the US.

RevitalVision is privately held and founder-owned, with no disclosed institutional venture capital, private equity, or strategic-parent backing identified in the available materials. The leadership team combines medical-device commercial experience (CEO Yair Yahav, formerly J&J Medical and Boston Scientific), software engineering depth (CTO Yogev Shamay, Technion), and operating/finance rigor (COO Yuval Ron-Ruhama, former Nasdaq CFO), supported by a scientific advisory board that includes internationally recognized pediatric ophthalmologists.

Name

RevitalVision

Legal name

Talshir Guy Medical Technologies Ltd.

Website

https://revitalvision.com

Company type

Private

Founded year

2020

Operating status

Operating

Headcount range

1–10 employees

Short description

RevitalVision is an Israel-based digital therapeutics company that sells FDA-cleared, web-based perceptual-learning software programs to improve vision in patients with amblyopia, eye diseases, and other vision impairments, distributed via direct-to-consumer e-commerce, eye-care clinic partners, and country-level distributors in Turkey and Vietnam.

Ownership category

akta.pro rank

Product category

Digital Vision Therapy Software

NAICS

Offices of Optometrists (62132), Scientific Research and Development Services (5417)

SIC

Services-Prepackaged Software (7372)

akta.pro primary industry

Vision Therapy & Orthoptics (HLAKAKAM)

akta.pro secondary industries

Pediatric Ophthalmology & Orthoptics Devices (Amblyopia Therapy, Strabismus Measurement & Treatment) (HLAHAJAM), Low Vision Rehabilitation (HLAKAKAJ), Neuro-Ophthalmology (HLAKAKAH)

Keywords

• Vision training software
• Digital therapeutics
• Neuroplasticity training
• Amblyopia treatment
• Perceptual learning

Headquarters

HQ city

Modi'in

HQ country

Israel

HQ region

Middle East

Offices3 records

Markets served

GTM type

B2C

Offering type

Software

Cost components

Technology or R&D, Personnel, Marketing or Sales, Operations, Others

Revenue model

1. Software License/Treatment Program Sales: Patients purchase access to the RevitalVision vision training software program. Programs are sold directly through the company website and online store, as well as through a network of ophthalmic and optometry clinics. The program requires a computer with internet access (15-27 inch screen) and consists of 30-40 training sessions over 2-4 months. Pricing is provided after completing an eligibility test.
2. Clinic/Enterprise Distribution: Ophthalmic and optometry clinics promote, sell, and monitor RevitalVision programs. Medical professionals can prescribe programs and remotely monitor patient progress. This B2B2C model enables wider distribution through healthcare providers.
3. International Distributor Partnerships: International distributors such as Vietcare Solutions (Vietnam) and Optik Medikal (Turkey) distribute RevitalVision products in their respective regions, likely through licensing or reseller arrangements.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels4 records

Core offering

RevitalVision develops and sells a home-based neuroplasticity vision training software platform that uses Gabor patch perceptual learning to stimulate the brain's visual cortex and improve vision. It offers condition-specific programs including FDA-cleared amblyopia treatment (ages 9+), presbyopia, post-cataract, low myopia, post-LASIK, sports vision, nystagmus, keratoconus, and other low vision programs, delivered via web application over 2-4 months of 30-minute sessions.

Product overview

RevitalVision offers a unified vision training software platform delivering multiple clinically-proven programs for various vision conditions. The platform uses perceptual learning technology with Gabor patch visual stimulation to train the brain's visual cortex. The product portfolio includes dedicated programs for Lazy Eye/Amblyopia (the only FDA-cleared indication), Presbyopia, Post-Cataract Surgery, Low Myopia, Sports Vision Training, Post-LASIK Surgery, Eye Diseases/Low Vision, Nystagmus, and Keratoconus. All programs share the same core platform technology but are customized for specific visual conditions through tailored visual tasks and difficulty adjustments.

Differentiator

Problem solved

Functional benefit

Products and services

• Lazy Eye / Amblyopia Program

Quantifiable outcome

• 2.5 lines average improvement on visual acuity chart
• +4 more outcomes

Named customers9 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Four partnerships are on record, tiered regional, minor and core.

• Optik Medikal (Turkey)regionalChannel Partner/ Reseller/ DistributorExclusive distributor for Turkey. Located at Meşrutiyet Mah. Valikonağı Cad. Valikonağı Plaza B Blok 177/8 34363 Nişantaşı, Istanbul. Contact: +90 212 225 90 50.
• Vietcare Solutions (Vietnam)regionalChannel Partner/ Reseller/ DistributorDistributor for Vietnam. Located at 270A Lý Thường Kiệt, Phường 14, Quận 10, TP.HCM. Contact: 028 36100016 - 0948 084 086.
• National Keratoconus FoundationminorStrategic or Co-development PartnerJoey Gase, MASCAR Driver, serves as Ambassador of the National Keratoconus Foundation and supports RevitalVision for keratoconus patients. The foundation raises awareness for keratoconus treatment options.
• Eye Care Clinics / Ophthalmic PartnerscoreChannel Partner/ Reseller/ DistributorGlobal network of ophthalmology and optometry clinics that promote, prescribe, and monitor RevitalVision programs for patients. Clinics include dedicated dashboard for patient progress monitoring.

Scale indicators7 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Luminopia: Luminopia is an FDA-cleared digital therapeutic for amblyopia in children using a dichoptic display approach. Directly comparable as a digital therapeutics competitor in the same FDA-regulated amblyopia category.
• CureSight: CureSight (by Tessellate BIO / Novasight-affiliated technology) is an eye-tracking-based digital amblyopia treatment cleared by FDA. Direct competitor in digital amblyopia therapeutics using a different mechanism (binocular treatment vs. RevitalVision's perceptual learning).
• NovaSight: NovaSight is an Israeli pediatric vision digital therapeutics company developing products for amblyopia and other pediatric vision disorders. Comparable Israeli peer in the same digital vision therapeutics category targeting similar clinical indications.
• Bynocs: Bynocs offers cloud-based amblyopia and vision training software delivered through optometry clinics internationally. Direct competitor with similar clinic-channel B2B2C business model for digital vision therapy.
• Vivid Vision: Vivid Vision provides VR-based vision therapy for amblyopia, strabismus, and other binocular vision disorders. Adjacent direct peer offering a digital platform for vision therapy in optometry clinics, competing for the same prescriber audience.
• AmblyoPlay: AmblyoPlay offers gamified vision training software for amblyopia and binocular vision conditions sold direct-to-consumer and via clinics. Comparable digital vision therapy competitor with similar home-based training model.

Broad incumbents

• Alcon: Alcon is a global leader in eye care spanning surgical, vision care, and ophthalmic pharmaceuticals. Broad incumbent whose surgical vision care franchise overlaps with RevitalVision's post-cataract and post-LASIK patient populations.
• Bausch + Lomb: Bausch + Lomb is a major ophthalmic company offering surgical, pharmaceutical, and consumer vision care products. Broad incumbent that addresses many of the same patient conditions (cataract, refractive error, dry eye) via different modalities.
• CooperVision: CooperVision is a global contact lens and vision care company. Its former Global Brand Director (Charles Morris) now leads RevitalVision's North America operations, indicating direct talent and market overlap with vision care delivery.
• Johnson & Johnson Vision: Johnson & Johnson Vision (now part of J&J MedTech) is a broad ophthalmic incumbent covering cataract surgery, refractive surgery, and contact lens products. Overlaps with RevitalVision's post-surgical vision treatment patient segments and where the CEO previously held a sales role.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/Revitalvision1

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles18 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about RevitalVision